Ceftriaxone lessens early ventilator-associated pneumonia in patients with brain injury

One dose of ceftriaxone lowered the risk for ventilator-associated pneumonia within the first week of mechanical ventilation among patients with acute brain injury, according to results published in The Lancet Respiratory Medicine.
In addition to this publication, findings from this study were presented at this year’s Society of Critical Care Medicine’s Critical Care Congress.
“[The] PROPHY-VAP trial confirms the protective effect of a single dose of two grams of ceftriaxone without application of [selective digestive decontamination] in brain-injured patients,” Claire

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart